Research ArticleClinical Studies
Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy
HYE SEON KANG, AH YOUNG SHIN, CHANG DONG YEO, SUNG KYOUNG KIM, CHAN KWON PARK, JU SANG KIM, SEUNG JOON KIM, SANG HAAK LEE and JIN WOO KIM
In Vivo November 2021, 35 (6) 3423-3430; DOI: https://doi.org/10.21873/invivo.12642
HYE SEON KANG
1Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
AH YOUNG SHIN
2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
CHANG DONG YEO
3Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
SUNG KYOUNG KIM
4Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
CHAN KWON PARK
5Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
JU SANG KIM
2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
SEUNG JOON KIM
6Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
SANG HAAK LEE
3Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea;
JIN WOO KIM
7Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
In this issue
In Vivo
Vol. 35, Issue 6
November-December 2021
Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy
HYE SEON KANG, AH YOUNG SHIN, CHANG DONG YEO, SUNG KYOUNG KIM, CHAN KWON PARK, JU SANG KIM, SEUNG JOON KIM, SANG HAAK LEE, JIN WOO KIM
In Vivo Nov 2021, 35 (6) 3423-3430; DOI: 10.21873/invivo.12642
Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy
HYE SEON KANG, AH YOUNG SHIN, CHANG DONG YEO, SUNG KYOUNG KIM, CHAN KWON PARK, JU SANG KIM, SEUNG JOON KIM, SANG HAAK LEE, JIN WOO KIM
In Vivo Nov 2021, 35 (6) 3423-3430; DOI: 10.21873/invivo.12642
Jump to section
Related Articles
- No related articles found.